Showing results (101-110 of 133) with videos related to
Sort By:
Pageof 14
Journal of Personalized Medicine|February 25, 2022
Androgen Receptor: A New Marker to Predict Pathological Complete Response in HER2-Positive Breast Cancer Patients Treated with Trastuzumab Plus Pertuzumab Neoadjuvant TherapyJiayi Li, Shuang Zhang, Chen Ye, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 23, 2020
Histo- and clinico-pathological analysis of a large series of triple-negative breast cancer in a single center in China: Evidences on necessity of histological subtyping and gradingShuang Zhang, Sixia Huang, Hong Zhang, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 4, 2015
Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapyShiwei Liu, Xuening Duan, Ling Xu, et al.Oncology Research and Treatment|July 10, 2026
Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance ImagingMiaomiao He, Feifei Zhu, Feng Jiang, et al.Anticancer Research|July 26, 2017
The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in ChinaJingming Ye, Wenjun Wang, Ling Xin, et al.Journal of Personalized Medicine|December 23, 2022
Correlation between Androgen Receptor Expression in Luminal B (HER-2 Negative) Breast Cancer and Disease OutcomesFan Yang, Jiayi Li, Hong Zhang, et al.Breast Cancer Research and Treatment|October 27, 2015
Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapyShiwei Liu, Xuening Duan, Ling Xu, et al.Cell Biology and Toxicology|January 3, 2021
S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathwaysDan Fang, Chengfei Zhang, Ping Xu, et al.Frontiers in Oncology|January 7, 2022
A Clinical-Radiomics Model for Predicting Axillary Pathologic Complete Response in Breast Cancer With Axillary Lymph Node MetastasesLiangyu Gan, Mingming Ma, Yinhua Liu, et al.Heliyon|May 22, 2023
A comparison between clinical decision support system and clinicians in breast cancerJianbin Li, Yang Yuan, Li Bian, et al.Pageof 14